OR-YEHUDA, Israel, April 6 /PRNewswire/ -- Do-Coop Technologies Ltd., a
privately held corporation based in Israel, announced today the commercial
availability of Neowater(TM) - Solubilization Enhancer, a new product that
enables or increases the solubility of hydrophobic, insoluble molecules and
drugs. As with the entire Neowater-based product line, the Solubilzation
Enhancer product is also generic, simple to use, and can be easily
incorporated into any type of compounds with dramatic results.
Neowater is an enabling technology that is based on breakthrough
water-based nanotechnology. Unlike traditional, dry nanotechnology, which
focuses on a nanoparticle end product, Neowater builds upon the unique
properties of nanoparticles to modify the physical properties of water
molecules around them.
Each nanoparticle within Neowater, with its huge surface, creates an
effect known as the "surface effect," and in turn organizes the water
molecules surrounding it. This is similar to the surface effect of
organelles within living cells. Both the organelles and the nanoparticles
use this unique mechanism to create intracellular water. While the former
is within cells and organs and cannot be harnessed nor used in a lab bench,
the latter one, which is branded as Neowater, can.
This technology, developed in Israel, produces water whose physical
properties mimic that of intracellular water using inorganic, insoluble
crystals introduced in water in a patented process. Neowater, with its
stable system of largely hydrated nano-particles, like non-ionic detergent
derived micelles, reduces the entropy of aqueous solutions. In addition, by
design, it exhibits both hydrophilic and hydrophobic properties.
Neowater-based products significantly accelerate and improve the
efficiency of biological reactions.
About Neowater(TM) - Solubilization Enhancer
"Biotech and Pharma companies have in their portfolios a significant
amount of compounds and drugs which have been proven effective in vitro,
yet they are very insoluble and thus unusable, such as novel cancer
therapeutic drugs. Neowater technology dramatically enhances the solubility
of those compounds that are difficult-to-solvate, or that are used with
common solvents but exhibit poor pharmacokinetics. Using our new product,
Biotech and Pharma companies can solubilize these compounds, enhance both
their stability and bio-availability, and thus can extend and protect their
intellectual property. We have packaged our enabling technology into this
unique new product that can replace polar solvents such as detergents and
surfactants, alcohols such as ethanol and other broadly used solvents like
DMSO. Furthermore, companies can alternatively use this product to reduce
the solubility of highly soluble, hydrophilic compounds. We anticipate that
Biotech and Pharma companies will use this product in laboratory tests with
their own problematic proprietary compounds and drugs, and then return to
us to license this unique capability from us. As with all of our other
products, Neowater(TM) - Solubilization Enhancer is very easy to use with
existing drugs and compounds, and without the need for new equipment or
processes," said Eran Gabbai, founder, President and CTO of Do-Coop
Technologies, and the inventor of Neowater technology.
Do-Coop Technologies is exhibiting (Booth number 2379) at the upcoming
BIO 2006 conference in Chicago, on April 9-12, 2006, and will also present
its Neowater technology at the Business Forum on Tuesday, April 11 at
09:34, room "E".
Do-Coop Technologies Ltd.
Irit Gabbai, +972-3-533-3804
SOURCE Do-Coop Technologies Ltd.